Follitropin alfa biosimilar (Allergan/Itero Biopharmaceuticals)

促卵泡激素α生物类似药 (Allergan/Itero Biopharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFollitropin alfa biosimilar (Allergan/Itero Biopharmaceuticals)

Drug Alias NamerFSH biosimilar促卵泡激素α生物仿制药 (Allergan/Itero Biopharmaceuticals)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants

TargetsFollicle-stimulating hormone receptor

Therapy Area/IndicationsInfertility

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesItero

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsInfertility

Inactive IndicationsN/A

ATC CodeG03GA05